Related Experiment Video
Updated: Sep 2, 2025
07:56
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
Published on: November 11, 2020
4.4K
Digital spacer data driven COPD inhaler adherence education: The OUTERSPACE proof-of-concept study
Boudewijn J H Dierick1, Sandra Been-Buck2, Titia Klemmeier2
1University of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of General Practice & Elderly Care Medicine, Groningen, the Netherlands.
Respiratory Medicine
|August 7, 2022
Summary
A new digital inhaler spacer improves technique and adherence in COPD patients. This smart device helps reduce errors, though larger studies are needed to confirm long-term clinical benefits.
Area of Science:
- Respiratory Medicine
- Digital Health Technology
- Pharmacology
Background:
- Pressurized metered dose inhalers (pMDIs) require spacers for optimal use, but patient technique and adherence are frequently inadequate.
- Poor inhaler technique can lead to reduced medication effectiveness and increased exacerbations in conditions like COPD.
- Novel digital tools are emerging to address these adherence and technique challenges.
Purpose of the Study:
- To assess the usability of a novel digital spacer in patients with COPD.
- To evaluate the impact of personalized education using the digital spacer on inhaler technique and adherence.
- To explore the effects of the digital spacer on long-term systemic drug exposure and clinical outcomes in COPD.
Main Methods:
- A proof-of-concept study involving COPD patients using a digital spacer.
- Usability was assessed through patient feedback.
- Inhaler technique errors were recorded by the digital spacer before and after personalized education.
- Systemic drug exposure was measured using bioanalytical scalp hair analysis for formoterol.
Main Results:
- The digital spacer demonstrated high usability among participants.
- Personalized education with the digital spacer significantly reduced daily inhaler technique errors by 36% (from 6.40 to 4.07 errors/day, p=0.038).
- Systemic exposure to formoterol was confirmed; however, no significant changes in clinical outcomes were observed in this short-term study.
Conclusions:
- The digital spacer shows promise as a valuable tool for improving inhaler education and technique in COPD patients.
- Personalized feedback from the digital spacer can lead to immediate improvements in inhaler technique.
- Larger and longer-term studies are necessary to fully establish the clinical utility and long-term impact of digital spacers in COPD management.
Related Concept Videos
01:23Inhaled Medications
371
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
371
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
287
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
287
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K